Review



nmda receptor blocker l 689 560  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Tocris nmda receptor blocker l 689 560
    Nmda Receptor Blocker L 689 560, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 64 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nmda+receptor+blocker+cpp/L-689%2C560/pmc06196267-87-23-37
    Average 93 stars, based on 64 article reviews
    nmda receptor blocker l 689 560 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: APP fragment controls both ionotropic and non-ionotropic signaling of NMDA receptors.
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-rabbit-IgG-HRP conjugated secondary antibody Jackson ImmunoResearch Cat#111-036-045; RRID: AB_2337943 Anti-rat-IgG-HRP conjugated secondary antibody Jackson ImmunoResearch Cat#111-036-062; RRID: AB_2338142 Anti-mouse-IgG-HRP conjugated secondary antibody Jackson ImmunoResearch Cat#111-036-146; RRID: AB_2307347 M3.2 Biolegend Cat#805701; RRID: AB_2564981 2D8 Sigma-Aldrich Cat#MABN2273 2E9 Sigma-Aldrich Cat#MABN2295 22C11 Merck Milipore Cat#MAB348 Y188 Abcam Cat#ab32136; RRID: AB_2289606 mCherry Takara Cat#632496; RRID: AB_10013483 Synaptophysin Sigma-Aldrich Cat#S5786 Synaptobrevin-2 SYSY Cat#104211 p-38 Cell Signaling Cat#8690; RRID: AB_10999090 p-p38 Cell Signaling Cat#9216; RRID: AB_331296 Beta-actin Sigma-Aldrich Cat#AC-74 Bacterial and virus strains AAV8-hSyn-hM3Dq-mCherry Addgene Cat#50474 AAV8-hSyn-hM4Di-mCherry Addgene Cat#50475 Chemicals, peptides, and recombinant proteins Glycine Euromedex Cat#26128 6405 L-Glutamate Sigma-Aldrich Cat#1446600 USP Cyclothiazide Biothechne Cat#07130-50 Poly-L-Lysine Sigma Aldrich Cat#P2636 Neurobasal medium (Gibco) Thermo Fisher Scientific Cat#21103049 B27 Thermo Fisher Scientific Cat#17504044 GlutaMAX Thermo Fisher Scientific Cat#35050061 Penicillin/streptomycin Thermo Fisher Scientific Cat#15140122 NaCl Sigma Aldrich Cat#560 14 KCl Sigma Aldrich Cat#P3911 CaCl2 Sigma Aldrich Cat#C8106 HEPES Sigma Aldrich Cat#H3375 Glucose VWR Cat#24379294 Tetrodotoxin Alomone Labs Cat#T-550 Cs-gluconate (Cesium Hydroxide) Sigma Aldrich Cat#232041 CsCl Sigma Aldrich Cat#289329 TEACl Sigma Aldrich Cat#86614 EGTA Sigma Aldrich Cat#E3889 MgATP Sigma Aldrich Cat#A9187 NaGTP Sigma Aldrich Cat#G8877 NMDA Tocris Cat#0114 Sucrose Sigma Aldrich Cat#S0389 (Continued on next page) Neuron 112, 2708–2720.e1–e9, August 21, 2024 e1 .. REAGENT or RESOURCE SOURCE IDENTIFIER NaH2PO4 Sigma Aldrich Cat#S9638 MgSO4 Sigma Aldrich Cat#230391 NaHCO3 Sigma Aldrich Cat#S6014 Gluconic acid (potassium salt: K-gluconate) Sigma Aldrich Cat#G1951 MgCl2 Sigma Aldrich Cat#M2670 Picrotoxin Sigma Aldrich Cat#P1675 DNQX Tocris Cat#2312 D-APV Tocris Cat#0106 NBQX Tocris Cat#0373 Cesium-methanesulfonate (Methanesulfonate) Sigma Aldrich Cat#64285 Na2ATP Sigma Aldrich Cat#A26209 cAMP Sigma Aldrich Cat#A9501 MK801 Sigma Aldrich Cat#M107 L689,560 Tocris Cat0742 Alexa Fluor 594 hydrazide Invitrogen Cat#A10438 Fluo-4 pentapotassium salt Invitrogen Cat#F14200 Fluo-5F pentapotassium salt Invitrogen Cat#F14221 MNI-caged-L-glutamate Tocris Cat#1490 Trolox Sigma Cat#238813 BrainPhys medium STEMCELL Technologies Cat#O5790 Ketamine Virbac Ketamine 1000 Xylazine Virbac Paxman LY2811376 Clinisciences Cat#HY-10472 40% PEG300 Fluka Cat#81160 5% Tween-80 Sigma-Aldrich Cat#P1754 CNO Enzo Cat#BML-NS105-0025 Acepromazine N/A Calmivet Hyaluronidase Sigma-Aldrich Cat#H4272 Diethylamine Sigma-Aldrich Cat#471216-5mL Tris-HCl VWR Cat#0234-500G Na2EDTA Sigma-Aldrich Cat#E6758-100g NP-40 nonidet Roche Cat#1175459900 Sodium deoxycholate Sigma-Aldrich Cat#D5670-25g Triton X-100 Sigma-Aldrich Cat#X100 Protease inhibitors Sigma-Aldrich Cat#P8340 Bradford Biorad Cat#5000205 Tris-Tricine gels Invitrogen Cat#EC66252BOX I-Block Thermo Fisher Scientific Cat#T2015 Tween 20 merck Sigma-Aldrich Cat#102423676 Ponceau Sigma-Aldrich Cat#P71-70 Chemiluminescence detection reagent ECL Perkin Elmer Cat#NEL112001EA TCN201 Tocris Cat#4154 DMSO Sigma-Aldrich Cat#D8418 Ifenprodil Sigma Aldrich Cat#I2892 D-Serine Sigma Aldrich Cat#S4250 Critical commercial assays Human/Rat (Mouse) b-Amyloid (40) ELISA Kit Wako Cat#294-62501 (Continued on next page) e2 Neuron 112, 2708–2720.e1–e9, August 21, 2024 .. REAGENT or RESOURCE SOURCE IDENTIFIER Golgi-Cox FD rapid GolgiStain kit, FD Neurotechnologies, USA FD Neurotechnologies Golgi stain Experimental models: Organisms/strains APPdelETA mice DZNE Munich -B6J- App (+em3) private MGI: 7281307 (under registration at Jackson Laboratories) AETA-m mice LMU Munich -Tg(Thy1-APP)A2haa private MGI: 7281720 (under registration at Jackson Laboratories) C57BL/6 Charles River RRID: IMSR_JAX:000664 Oligonucleotides APPintron11-12for Eurogentec AAGCTCTGACTTTCCTTAAGGTGC APPintron12-13rev Eurogentec TAGGAGTGGTATCCCTGCGGGT AETA Peptide Specialty Laboratories (PSL GmbH), Munich, Germany MISEPRISYGNDALMPSLTETKTTVE LLPVNGEFSLDDLQPWHSFGADSVPANTE NEVEPVDARPAADRGLTTRPGSG LTNIKTEEISEVKMDAEFRHDSGYEVHHQK CtrlP Peptide Specialty Laboratories (PSL GmbH), Munich, Germany KQHHVEYGSDHRFEADMKVESIEETKINTL GSGPRTTLGRDAAPRADVPEVENETNA PVSDAGFSHWPQLDDLSFEGNVPLLE VTTKTETLSPMLADNGYSIRPESIM crRNA APP-Ex12dn IDT CGCTCTCATGCCTTCGCTGA crRNA APP-Ex12up IDT AACTACTCCGACGATGTCT Recombinant DNA Human GluN1-1a Dr Laube, TU Darmstadt, Germany Platzer et al.48 Human GluN2A Dr Laube, TU Darmstadt, Germany Platzer et al.48 Human GluN2B Dr Laube, TU Darmstadt, Germany Platzer et al.48 Rat GluN1-1a Dr Paoletti, IBENS, France Mony et al.49 Rat GluN2A Dr Paoletti, IBENS, France Mony et al.49 Rat GluN2B Dr Paoletti, IBENS, France Mony et al.49 Rat GluA1 Dr Kristensen, University of Copenhagen, Denmark Stenum-Berg et al.50 Rat GluA2R Dr Kristensen, University of Copenhagen, Denmark Stenum-Berg et al.50 Rat GluA3 Dr Kristensen, University of Copenhagen, Denmark Stenum-Berg et al.50 GluN1-GFP Dr De Koninck, CERVO Brain Research Center, Canada Doré et al.51 GluN1-mCherry Dr De Koninck, CERVO Brain Research Center, Canada Doré et al.51 Flag-GluN2B Dr Groc, IINS, France Ferreira et al.19 Software and algorithms GraphPad Prism 9 Dotmatics Academic module Packwin; freezing module Panlab N/A Clampfit 10.6 Axon Instruments N/A Clampex Molecular Devices N/A Multiclamp Molecular Devices N/A

    other:

    Article Title: Metaplastic priming enables non-ionotropic NMDA receptor-mediated synaptic depotentiation in the hippocampus
    Article Snippet: The glutamate-site specific NMDAR antagonist D-(-)2-Amino-5-phosphonopentanoic acid (APV) was obtained from HelloBio (Bristol, United Kingdom), and the glycine-site specific NMDAR antagonist L-689,560 (L689) was obtained from Tocris Bioscience (Biotechne, Minneapolis, Minnesota, United States).



    Similar Products

    95
    Bio-Techne corporation nmda receptor blocker
    a Schematics of cerebellar circuit. b UMAP embedding showing normalized expression of gene involved in mGluR1 signaling cascade. c Same as in b <t>for</t> <t>AMPA</t> and <t>NMDA</t> receptors. d Same as in b for genes involved in mGluR2/3 signaling cascade. e Example spiking responses in different UBCs to a burst of MF input (20 stimuli at 100 Hz). f Instantaneous firing rate for the same cells.
    Nmda Receptor Blocker, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nmda+receptor+blocker+cpp/(R)-CPP/pmc08497507-229-45-36
    Average 95 stars, based on 1 article reviews
    nmda receptor blocker - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Tocris nmda receptor blocker
    a Schematics of cerebellar circuit. b UMAP embedding showing normalized expression of gene involved in mGluR1 signaling cascade. c Same as in b <t>for</t> <t>AMPA</t> and <t>NMDA</t> receptors. d Same as in b for genes involved in mGluR2/3 signaling cascade. e Example spiking responses in different UBCs to a burst of MF input (20 stimuli at 100 Hz). f Instantaneous firing rate for the same cells.
    Nmda Receptor Blocker, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nmda+receptor+blocker+cpp/(R)-CPP/pmc08497507-229-45-56
    Average 95 stars, based on 1 article reviews
    nmda receptor blocker - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    94
    Tocris nmda receptor blocker rs
    a Schematics of cerebellar circuit. b UMAP embedding showing normalized expression of gene involved in mGluR1 signaling cascade. c Same as in b <t>for</t> <t>AMPA</t> and <t>NMDA</t> receptors. d Same as in b for genes involved in mGluR2/3 signaling cascade. e Example spiking responses in different UBCs to a burst of MF input (20 stimuli at 100 Hz). f Instantaneous firing rate for the same cells.
    Nmda Receptor Blocker Rs, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nmda+receptor+blocker+cpp/(RS)-CPP/pmc04212060-324-27-50
    Average 94 stars, based on 1 article reviews
    nmda receptor blocker rs - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    Doshisha Corporation nmda receptor blocker cpp
    a Schematics of cerebellar circuit. b UMAP embedding showing normalized expression of gene involved in mGluR1 signaling cascade. c Same as in b <t>for</t> <t>AMPA</t> and <t>NMDA</t> receptors. d Same as in b for genes involved in mGluR2/3 signaling cascade. e Example spiking responses in different UBCs to a burst of MF input (20 stimuli at 100 Hz). f Instantaneous firing rate for the same cells.
    Nmda Receptor Blocker Cpp, supplied by Doshisha Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nmda+receptor+blocker+cpp/nmda+receptor+blocker+cpp/pm24669503-2-166-154
    Average 90 stars, based on 1 article reviews
    nmda receptor blocker cpp - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    a Schematics of cerebellar circuit. b UMAP embedding showing normalized expression of gene involved in mGluR1 signaling cascade. c Same as in b for AMPA and NMDA receptors. d Same as in b for genes involved in mGluR2/3 signaling cascade. e Example spiking responses in different UBCs to a burst of MF input (20 stimuli at 100 Hz). f Instantaneous firing rate for the same cells.

    Journal: Nature Communications

    Article Title: Graded heterogeneity of metabotropic signaling underlies a continuum of cell-intrinsic temporal responses in unipolar brush cells

    doi: 10.1038/s41467-021-22893-8

    Figure Lengend Snippet: a Schematics of cerebellar circuit. b UMAP embedding showing normalized expression of gene involved in mGluR1 signaling cascade. c Same as in b for AMPA and NMDA receptors. d Same as in b for genes involved in mGluR2/3 signaling cascade. e Example spiking responses in different UBCs to a burst of MF input (20 stimuli at 100 Hz). f Instantaneous firing rate for the same cells.

    Article Snippet: Sequential drug wash-ins were performed using a computer-controlled solenoid manifold system (ValveLink 8.2, Automate Scientific, Inc., Berkeley, CA) with a flow rate of 1 to 2 mL/min, where indicated, with mGluR1 antagonist (100 µM LY357385, Tocris Bio-Techne, Minneapolis, MN), AMPA receptor blocker (5 µM NBQX), NMDA receptor blocker (2 µM R-CPP), mGluR2/3 antagonist (1 µM LY341495, Tocris Bio-Techne, Minneapolis, MN) and DGK inhibitor II (100 µM R59949, MilliporeSigma, St. Louis, MO)

    Techniques: Expressing

    a Examples of instantaneous firing rate from on-cell recordings before (black) and after (gray) the application of AMPA/NMDA receptor antagonist (gray bar) in a fast (left) and a slow (right) UBC. Each trace is an average of 8 trials. b Summary of evoked spiking (20 × 100 Hz) and the effect of AMPA/NMDA receptor antagonist (normalized to baseline, mean ± sem, n = 5). c Examples of instantaneous firing rate from on-cell recordings before (black) and after (red) the application of an mGluR1 antagonist (red bar) in a fast (left) and a slow (right) UBC. Each trace is an average of 8 trials. d Summary of evoked spiking (20 × 100 Hz) and the effect of an mGluR1 antagonist (normalized to baseline, mean±sem, n = 5). e Example of instantaneous firing rate before and after 20 minutes of DGK inhibitor II wash-in. f Summary of half-decay time of instantaneous firing rate response with DGK inhibitor II (normalized to baseline, mean ± sem, n = 6). g Summary of peak amplitude of instantaneous firing rate response with DGK inhibitor II (normalized to baseline, mean±sem, n = 6).

    Journal: Nature Communications

    Article Title: Graded heterogeneity of metabotropic signaling underlies a continuum of cell-intrinsic temporal responses in unipolar brush cells

    doi: 10.1038/s41467-021-22893-8

    Figure Lengend Snippet: a Examples of instantaneous firing rate from on-cell recordings before (black) and after (gray) the application of AMPA/NMDA receptor antagonist (gray bar) in a fast (left) and a slow (right) UBC. Each trace is an average of 8 trials. b Summary of evoked spiking (20 × 100 Hz) and the effect of AMPA/NMDA receptor antagonist (normalized to baseline, mean ± sem, n = 5). c Examples of instantaneous firing rate from on-cell recordings before (black) and after (red) the application of an mGluR1 antagonist (red bar) in a fast (left) and a slow (right) UBC. Each trace is an average of 8 trials. d Summary of evoked spiking (20 × 100 Hz) and the effect of an mGluR1 antagonist (normalized to baseline, mean±sem, n = 5). e Example of instantaneous firing rate before and after 20 minutes of DGK inhibitor II wash-in. f Summary of half-decay time of instantaneous firing rate response with DGK inhibitor II (normalized to baseline, mean ± sem, n = 6). g Summary of peak amplitude of instantaneous firing rate response with DGK inhibitor II (normalized to baseline, mean±sem, n = 6).

    Article Snippet: Sequential drug wash-ins were performed using a computer-controlled solenoid manifold system (ValveLink 8.2, Automate Scientific, Inc., Berkeley, CA) with a flow rate of 1 to 2 mL/min, where indicated, with mGluR1 antagonist (100 µM LY357385, Tocris Bio-Techne, Minneapolis, MN), AMPA receptor blocker (5 µM NBQX), NMDA receptor blocker (2 µM R-CPP), mGluR2/3 antagonist (1 µM LY341495, Tocris Bio-Techne, Minneapolis, MN) and DGK inhibitor II (100 µM R59949, MilliporeSigma, St. Louis, MO)

    Techniques:

    a Sample cell-attached recording (top) instantaneous firing rate (middle) and synaptic current measured with whole-cell voltage clamp (bottom) in a cell with fast response. b Same as in a but for a cell with intermediate speed response. c Same as in a but for a cell with clear biphasic synaptic current (bottom). d Same as in a but for a cell with slow biphasic response. e Same as in a but for a cell with only a pause in firing. f Half-decay times of firing rates vs. half-decay times of currents and linear fit on a log-log plot ( R adj 2 = 0.91, slope = 0.88, intercept = −0.22, n = 17). g Peak firing rate vs. peak current amplitude and linear fit on a log-log plot ( R adj 2 = 0.69, slope = 0.71, intercept = −0.65, n = 17). h Pause duration vs. amplitude of the current at stimulation offset, and linear fit with log 10 response variable (black, R adj 2 = 0.44, slope = 0.01, intercept = −0.42, n = 20). i Heatmap of peak normalized mGluR1-mediated current ( n = 10). j Heatmap of peak normalized mGluR2/3-mediated current ( n = 7). k Average synaptic response before (black), after (red) mGluR1 antagonist, and after AMPA/NMDA receptor antagonist wash-ins (gray). Each trace is an average of 8 trials. l Average synaptic response before (top, black) and after (top, blue) mGluR2/3 antagonist wash-in, and their difference (bottom, black). Each trace is an average of 8 trials.

    Journal: Nature Communications

    Article Title: Graded heterogeneity of metabotropic signaling underlies a continuum of cell-intrinsic temporal responses in unipolar brush cells

    doi: 10.1038/s41467-021-22893-8

    Figure Lengend Snippet: a Sample cell-attached recording (top) instantaneous firing rate (middle) and synaptic current measured with whole-cell voltage clamp (bottom) in a cell with fast response. b Same as in a but for a cell with intermediate speed response. c Same as in a but for a cell with clear biphasic synaptic current (bottom). d Same as in a but for a cell with slow biphasic response. e Same as in a but for a cell with only a pause in firing. f Half-decay times of firing rates vs. half-decay times of currents and linear fit on a log-log plot ( R adj 2 = 0.91, slope = 0.88, intercept = −0.22, n = 17). g Peak firing rate vs. peak current amplitude and linear fit on a log-log plot ( R adj 2 = 0.69, slope = 0.71, intercept = −0.65, n = 17). h Pause duration vs. amplitude of the current at stimulation offset, and linear fit with log 10 response variable (black, R adj 2 = 0.44, slope = 0.01, intercept = −0.42, n = 20). i Heatmap of peak normalized mGluR1-mediated current ( n = 10). j Heatmap of peak normalized mGluR2/3-mediated current ( n = 7). k Average synaptic response before (black), after (red) mGluR1 antagonist, and after AMPA/NMDA receptor antagonist wash-ins (gray). Each trace is an average of 8 trials. l Average synaptic response before (top, black) and after (top, blue) mGluR2/3 antagonist wash-in, and their difference (bottom, black). Each trace is an average of 8 trials.

    Article Snippet: Sequential drug wash-ins were performed using a computer-controlled solenoid manifold system (ValveLink 8.2, Automate Scientific, Inc., Berkeley, CA) with a flow rate of 1 to 2 mL/min, where indicated, with mGluR1 antagonist (100 µM LY357385, Tocris Bio-Techne, Minneapolis, MN), AMPA receptor blocker (5 µM NBQX), NMDA receptor blocker (2 µM R-CPP), mGluR2/3 antagonist (1 µM LY341495, Tocris Bio-Techne, Minneapolis, MN) and DGK inhibitor II (100 µM R59949, MilliporeSigma, St. Louis, MO)

    Techniques:

    a Schematics of cerebellar circuit. b UMAP embedding showing normalized expression of gene involved in mGluR1 signaling cascade. c Same as in b for AMPA and NMDA receptors. d Same as in b for genes involved in mGluR2/3 signaling cascade. e Example spiking responses in different UBCs to a burst of MF input (20 stimuli at 100 Hz). f Instantaneous firing rate for the same cells.

    Journal: Nature Communications

    Article Title: Graded heterogeneity of metabotropic signaling underlies a continuum of cell-intrinsic temporal responses in unipolar brush cells

    doi: 10.1038/s41467-021-22893-8

    Figure Lengend Snippet: a Schematics of cerebellar circuit. b UMAP embedding showing normalized expression of gene involved in mGluR1 signaling cascade. c Same as in b for AMPA and NMDA receptors. d Same as in b for genes involved in mGluR2/3 signaling cascade. e Example spiking responses in different UBCs to a burst of MF input (20 stimuli at 100 Hz). f Instantaneous firing rate for the same cells.

    Article Snippet: Sequential drug wash-ins were performed using a computer-controlled solenoid manifold system (ValveLink 8.2, Automate Scientific, Inc., Berkeley, CA) with a flow rate of 1 to 2 mL/min, where indicated, with mGluR1 antagonist (100 μM LY357385, Tocris Bio-Techne, Minneapolis, MN), AMPA receptor blocker (5 μM NBQX), NMDA receptor blocker (2 μM R-CPP), mGluR2/3 antagonist (1 μM LY341495, Tocris Bio-Techne, Minneapolis, MN) and DGK inhibitor II (100 μM R59949, MilliporeSigma, St. Louis, MO)

    Techniques: Expressing

    a Examples of instantaneous firing rate from on-cell recordings before (black) and after (gray) the application of AMPA/NMDA receptor antagonist (gray bar) in a fast (left) and a slow (right) UBC. Each trace is an average of 8 trials. b Summary of evoked spiking (20 × 100 Hz) and the effect of AMPA/NMDA receptor antagonist (normalized to baseline, mean ± sem, n = 5). c Examples of instantaneous firing rate from on-cell recordings before (black) and after (red) the application of an mGluR1 antagonist (red bar) in a fast (left) and a slow (right) UBC. Each trace is an average of 8 trials. d Summary of evoked spiking (20 × 100 Hz) and the effect of an mGluR1 antagonist (normalized to baseline, mean±sem, n = 5). e Example of instantaneous firing rate before and after 20 minutes of DGK inhibitor II wash-in. f Summary of half-decay time of instantaneous firing rate response with DGK inhibitor II (normalized to baseline, mean ± sem, n = 6). g Summary of peak amplitude of instantaneous firing rate response with DGK inhibitor II (normalized to baseline, mean±sem, n = 6).

    Journal: Nature Communications

    Article Title: Graded heterogeneity of metabotropic signaling underlies a continuum of cell-intrinsic temporal responses in unipolar brush cells

    doi: 10.1038/s41467-021-22893-8

    Figure Lengend Snippet: a Examples of instantaneous firing rate from on-cell recordings before (black) and after (gray) the application of AMPA/NMDA receptor antagonist (gray bar) in a fast (left) and a slow (right) UBC. Each trace is an average of 8 trials. b Summary of evoked spiking (20 × 100 Hz) and the effect of AMPA/NMDA receptor antagonist (normalized to baseline, mean ± sem, n = 5). c Examples of instantaneous firing rate from on-cell recordings before (black) and after (red) the application of an mGluR1 antagonist (red bar) in a fast (left) and a slow (right) UBC. Each trace is an average of 8 trials. d Summary of evoked spiking (20 × 100 Hz) and the effect of an mGluR1 antagonist (normalized to baseline, mean±sem, n = 5). e Example of instantaneous firing rate before and after 20 minutes of DGK inhibitor II wash-in. f Summary of half-decay time of instantaneous firing rate response with DGK inhibitor II (normalized to baseline, mean ± sem, n = 6). g Summary of peak amplitude of instantaneous firing rate response with DGK inhibitor II (normalized to baseline, mean±sem, n = 6).

    Article Snippet: Sequential drug wash-ins were performed using a computer-controlled solenoid manifold system (ValveLink 8.2, Automate Scientific, Inc., Berkeley, CA) with a flow rate of 1 to 2 mL/min, where indicated, with mGluR1 antagonist (100 μM LY357385, Tocris Bio-Techne, Minneapolis, MN), AMPA receptor blocker (5 μM NBQX), NMDA receptor blocker (2 μM R-CPP), mGluR2/3 antagonist (1 μM LY341495, Tocris Bio-Techne, Minneapolis, MN) and DGK inhibitor II (100 μM R59949, MilliporeSigma, St. Louis, MO)

    Techniques:

    a Sample cell-attached recording (top) instantaneous firing rate (middle) and synaptic current measured with whole-cell voltage clamp (bottom) in a cell with fast response. b Same as in a but for a cell with intermediate speed response. c Same as in a but for a cell with clear biphasic synaptic current (bottom). d Same as in a but for a cell with slow biphasic response. e Same as in a but for a cell with only a pause in firing. f Half-decay times of firing rates vs. half-decay times of currents and linear fit on a log-log plot ( R adj 2 = 0.91, slope = 0.88, intercept = −0.22, n = 17). g Peak firing rate vs. peak current amplitude and linear fit on a log-log plot ( R adj 2 = 0.69, slope = 0.71, intercept = −0.65, n = 17). h Pause duration vs. amplitude of the current at stimulation offset, and linear fit with log 10 response variable (black, R adj 2 = 0.44, slope = 0.01, intercept = −0.42, n = 20). i Heatmap of peak normalized mGluR1-mediated current ( n = 10). j Heatmap of peak normalized mGluR2/3-mediated current ( n = 7). k Average synaptic response before (black), after (red) mGluR1 antagonist, and after AMPA/NMDA receptor antagonist wash-ins (gray). Each trace is an average of 8 trials. l Average synaptic response before (top, black) and after (top, blue) mGluR2/3 antagonist wash-in, and their difference (bottom, black). Each trace is an average of 8 trials.

    Journal: Nature Communications

    Article Title: Graded heterogeneity of metabotropic signaling underlies a continuum of cell-intrinsic temporal responses in unipolar brush cells

    doi: 10.1038/s41467-021-22893-8

    Figure Lengend Snippet: a Sample cell-attached recording (top) instantaneous firing rate (middle) and synaptic current measured with whole-cell voltage clamp (bottom) in a cell with fast response. b Same as in a but for a cell with intermediate speed response. c Same as in a but for a cell with clear biphasic synaptic current (bottom). d Same as in a but for a cell with slow biphasic response. e Same as in a but for a cell with only a pause in firing. f Half-decay times of firing rates vs. half-decay times of currents and linear fit on a log-log plot ( R adj 2 = 0.91, slope = 0.88, intercept = −0.22, n = 17). g Peak firing rate vs. peak current amplitude and linear fit on a log-log plot ( R adj 2 = 0.69, slope = 0.71, intercept = −0.65, n = 17). h Pause duration vs. amplitude of the current at stimulation offset, and linear fit with log 10 response variable (black, R adj 2 = 0.44, slope = 0.01, intercept = −0.42, n = 20). i Heatmap of peak normalized mGluR1-mediated current ( n = 10). j Heatmap of peak normalized mGluR2/3-mediated current ( n = 7). k Average synaptic response before (black), after (red) mGluR1 antagonist, and after AMPA/NMDA receptor antagonist wash-ins (gray). Each trace is an average of 8 trials. l Average synaptic response before (top, black) and after (top, blue) mGluR2/3 antagonist wash-in, and their difference (bottom, black). Each trace is an average of 8 trials.

    Article Snippet: Sequential drug wash-ins were performed using a computer-controlled solenoid manifold system (ValveLink 8.2, Automate Scientific, Inc., Berkeley, CA) with a flow rate of 1 to 2 mL/min, where indicated, with mGluR1 antagonist (100 μM LY357385, Tocris Bio-Techne, Minneapolis, MN), AMPA receptor blocker (5 μM NBQX), NMDA receptor blocker (2 μM R-CPP), mGluR2/3 antagonist (1 μM LY341495, Tocris Bio-Techne, Minneapolis, MN) and DGK inhibitor II (100 μM R59949, MilliporeSigma, St. Louis, MO)

    Techniques: